Clinical trial
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients…
NCT00416598 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00416598 |
|---|---|
| Title | Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia |
| Official title | Phase II Study of Maintenance Therapy With Decitabine (NSC #127716) Following Standard Induction and Cytogenetic Risk-Adapted Intensification in Previously Untreated Patients With AML < 60 Years |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22), CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16, 16)(p13.1, q22), Adult Acute Myeloid Leukemia With t(8, 21), (q22 and 7 more |
| Intervention type | Biological, Drug, Other, Procedure |
| Interventions | Autologous Bone Marrow Transplantation, Autologous Hematopoietic Stem Cell Transplantation, Busulfan, Cytarabine, Daunorubicin Hydrochloride, Decitabine, Etoposide, Filgrastim, Laboratory Biomarker Analysis, Pharmacological Study |
| Enrollment | 546 |
| Start date | Nov 15, 2006 |
| Primary completion | Jan 31, 2011 |
| Completion | Dec 1, 2016 |
| First posted | Dec 28, 2006 |
| Last update posted | Feb 19, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: